Use of parvovirus for eliminating cancer stem cells (CSCs)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9700588
SERIAL NO

13807736

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described is the use of a parvovirus, preferably H-1PV, for the therapeutical elimination of cancer stem cells (CSCs), preferably neuroblastoma stem cells and glioblastoma stem cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEUTSCHES KREBSFORSCHUNGSZENTRUMIM NEUENHEIMER FELD 280 HEIDELBERG 69120
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERGGRABENGASSE 1 HEIDELBERG D-69117

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deubzer, Elisabeth Hedwig Heidelberg, DE 2 4
Geletneky, Karsten Heidelberg, DE 15 44
Herold-Mende, Christel Bammental, DE 7 15
Kern, Sonja Wuerzburg, DE 2 4
Lacroix, Jeannine Heidelberg, DE 2 4
Leuchs, Barbara Heidelberg, DE 19 15
Rommelaere, Jean Heidelberg, DE 48 78
Schlehofer, Joerg Leimen, DE 6 18
Witt, Olaf Schriesheim, DE 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 11, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00